Overview

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Norfloxacin